Click here to get full coverage on AQST Investor Alert: AQUESTIVE THERAPEUTICS, INC. - GlobeNewswire

AQST Investor Alert: AQUESTIVE THERAPEUTICS, INC.  GlobeNewswire

AQST Investor Alert: AQUESTIVE THERAPEUTICS, INC. - GlobeNewswire

Click here to get full coverage on Aquestive Therapeutics (AQST) Awaits Anaphylm NDA Approval in Q3 - Yahoo Finance

Aquestive Therapeutics (AQST) Awaits Anaphylm NDA Approval in Q3  Yahoo Finance

Aquestive Therapeutics (AQST) Awaits Anaphylm NDA Approval in Q3 - Yahoo Finance

Click here to get full coverage on AQST Investors Have Opportunity to Lead Aquestive Therapeutics, Inc. Securities Fraud Lawsuit - Morningstar

AQST Investors Have Opportunity to Lead Aquestive Therapeutics, Inc. Securities Fraud Lawsuit  Morningstar

AQST Investors Have Opportunity to Lead Aquestive Therapeutics, Inc. Securities Fraud Lawsuit - Morningstar

Click here to get full coverage on AQST Stock Chart | AQUESTIVE THERAPEUTICS INC (NASDAQ:AQST) - ChartMill

AQST Stock Chart | AQUESTIVE THERAPEUTICS INC (NASDAQ:AQST)  ChartMill

AQST Stock Chart | AQUESTIVE THERAPEUTICS INC (NASDAQ:AQST) - ChartMill

Click here to get full coverage on AQST INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Aquestive Therapeutics (AQST) Investors of Securities Class Action Deadline on May 4, 2026 - PR Newswire

AQST INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Aquestive Therapeutics (AQST) Investors of Securities Class Action Deadline on May 4, 2026  PR Newswire

AQST INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Aquestive Therapeutics (AQST) Investors of Securities Class Action Deadline on May 4, 2026 - PR Newswire

Click here to get full coverage on Here's Why Aquestive Therapeutics (AQST) Is a Great 'Buy the Bottom' Stock Now - Eastern Progress

Here's Why Aquestive Therapeutics (AQST) Is a Great 'Buy the Bottom' Stock Now  Eastern Progress

Here's Why Aquestive Therapeutics (AQST) Is a Great 'Buy the Bottom' Stock Now - Eastern Progress

Click here to get full coverage on AQST Shareholder Alert: Aquestive Therapeutics, Inc. - GlobeNewswire

AQST Shareholder Alert: Aquestive Therapeutics, Inc.  GlobeNewswire

AQST Shareholder Alert: Aquestive Therapeutics, Inc. - GlobeNewswire

Click here to get full coverage on Aquestive Therapeutics, Inc. (NASDAQ:AQST) Analysts Just Trimmed Their Revenue Forecasts By 26% - Yahoo Finance

Aquestive Therapeutics, Inc. (NASDAQ:AQST) Analysts Just Trimmed Their Revenue Forecasts By 26%  Yahoo Finance

Aquestive Therapeutics, Inc. (NASDAQ:AQST) Analysts Just Trimmed Their Revenue Forecasts By 26% - Yahoo Finance

Click here to get full coverage on INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Aquestive Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - AQST - PR Newswire

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Aquestive Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - AQST  PR Newswire

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Aquestive Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - AQST - PR Newswire

Click here to get full coverage on AQST Investors Have Opportunity to Lead Aquestive Therapeutics, Inc. Securities Fraud Lawsuit - ChartMill

AQST Investors Have Opportunity to Lead Aquestive Therapeutics, Inc. Securities Fraud Lawsuit  ChartMill

AQST Investors Have Opportunity to Lead Aquestive Therapeutics, Inc. Securities Fraud Lawsuit - ChartMill

Click here to get full coverage on Compared to Estimates, Aquestive Therapeutics (AQST) Q4 Earnings: A Look at Key Metrics - Eastern Progress

Compared to Estimates, Aquestive Therapeutics (AQST) Q4 Earnings: A Look at Key Metrics  Eastern Progress

Compared to Estimates, Aquestive Therapeutics (AQST) Q4 Earnings: A Look at Key Metrics - Eastern Progress

Click here to get full coverage on Lead Plaintiff Deadlines in Shareholder Class Action - GlobeNewswire

Lead Plaintiff Deadlines in Shareholder Class Action  GlobeNewswire

Lead Plaintiff Deadlines in Shareholder Class Action - GlobeNewswire

Click here to get full coverage on Why Aquestive Therapeutics (AQST) Is Down 39.4% After FDA Flags Deficiencies In Anaphylm Application – And What's Next - Yahoo Finance

Why Aquestive Therapeutics (AQST) Is Down 39.4% After FDA Flags Deficiencies In Anaphylm Application – And What's Next  Yahoo Finance

Why Aquestive Therapeutics (AQST) Is Down 39.4% After FDA Flags Deficiencies In Anaphylm Application – And What's Next - Yahoo Finance

Click here to get full coverage on AQST Lawsuit Alleges Allegedly Concealed Anaphylm NDA Deficiencies - AQUESTIVE THERAPEUTICS, INC. Investors Face Losses Following Allegedly Concealed Anaphylm NDA Deficiencies: SueWallSt - PR Newswire

AQST Lawsuit Alleges Allegedly Concealed Anaphylm NDA Deficiencies - AQUESTIVE THERAPEUTICS, INC. Investors Face Losses Following Allegedly Concealed Anaphylm NDA Deficiencies: SueWallSt  PR Newswire

AQST Lawsuit Alleges Allegedly Concealed Anaphylm NDA Deficiencies - AQUESTIVE THERAPEUTICS, INC. Investors Face Losses Following Allegedly Concealed Anaphylm NDA Deficiencies: SueWallSt - PR Newswire

Click here to get full coverage on Assessing Aquestive Therapeutics (AQST) Valuation After FDA Flags Anaphylm Application Deficiencies - Yahoo Finance

Assessing Aquestive Therapeutics (AQST) Valuation After FDA Flags Anaphylm Application Deficiencies  Yahoo Finance

Assessing Aquestive Therapeutics (AQST) Valuation After FDA Flags Anaphylm Application Deficiencies - Yahoo Finance

Click here to get full coverage on Aquestive Therapeutics (AQST) Reports Q4 Loss, Misses Revenue Estimates - Yahoo Finance

Aquestive Therapeutics (AQST) Reports Q4 Loss, Misses Revenue Estimates  Yahoo Finance

Aquestive Therapeutics (AQST) Reports Q4 Loss, Misses Revenue Estimates - Yahoo Finance

Click here to get full coverage on Down 37% in 4 Weeks, Here's Why Aquestive Therapeutics (AQST) Looks Ripe for a Turnaround - Yahoo Finance

Down 37% in 4 Weeks, Here's Why Aquestive Therapeutics (AQST) Looks Ripe for a Turnaround  Yahoo Finance

Down 37% in 4 Weeks, Here's Why Aquestive Therapeutics (AQST) Looks Ripe for a Turnaround - Yahoo Finance

Click here to get full coverage on Breakeven On The Horizon For Aquestive Therapeutics, Inc. (NASDAQ:AQST) - Yahoo Finance

Breakeven On The Horizon For Aquestive Therapeutics, Inc. (NASDAQ:AQST)  Yahoo Finance

Breakeven On The Horizon For Aquestive Therapeutics, Inc. (NASDAQ:AQST) - Yahoo Finance

Click here to get full coverage on Aquestive Therapeutics (AQST) Upgraded to Buy: Here's Why - Yahoo Finance

Aquestive Therapeutics (AQST) Upgraded to Buy: Here's Why  Yahoo Finance

Aquestive Therapeutics (AQST) Upgraded to Buy: Here's Why - Yahoo Finance

Click here to get full coverage on Lake Street Adjusts Aquestive Therapeutics, Inc. (AQST) Valuation Model on Expected Approval Delay - Yahoo Finance

Lake Street Adjusts Aquestive Therapeutics, Inc. (AQST) Valuation Model on Expected Approval Delay  Yahoo Finance

Lake Street Adjusts Aquestive Therapeutics, Inc. (AQST) Valuation Model on Expected Approval Delay - Yahoo Finance

Click here to get full coverage on ROSEN, A TOP RANKED LAW FIRM, Encourages Aquestive Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AQST - TMX Newsfile

ROSEN, A TOP RANKED LAW FIRM, Encourages Aquestive Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AQST  TMX Newsfile

ROSEN, A TOP RANKED LAW FIRM, Encourages Aquestive Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AQST - TMX Newsfile

Click here to get full coverage on AQUESTIVE THERAPEUTICS, INC. (AQST) DEADLINE ALERT Bernstein Liebhard LLP Reminds Aquestive Therapeutics, Inc. Investors of Upcoming Deadline - TMX Newsfile

AQUESTIVE THERAPEUTICS, INC. (AQST) DEADLINE ALERT Bernstein Liebhard LLP Reminds Aquestive Therapeutics, Inc. Investors of Upcoming Deadline  TMX Newsfile

AQUESTIVE THERAPEUTICS, INC. (AQST) DEADLINE ALERT Bernstein Liebhard LLP Reminds Aquestive Therapeutics, Inc. Investors of Upcoming Deadline - TMX Newsfile

Click here to get full coverage on AQST Investor Alert: AQUESTIVE THERAPEUTICS, INC. Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Analyst Slashed Price Target: Levi & Korsinsky - Morningstar

AQST Investor Alert: AQUESTIVE THERAPEUTICS, INC. Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Analyst Slashed Price Target: Levi & Korsinsky  Morningstar

AQST Investor Alert: AQUESTIVE THERAPEUTICS, INC. Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Analyst Slashed Price Target: Levi & Korsinsky - Morningstar

Click here to get full coverage on Does Aquestive Therapeutics (AQST) FDA Packaging Setback Reframe the Risk‑Reward in Its Allergy Franchise? - Yahoo Finance

Does Aquestive Therapeutics (AQST) FDA Packaging Setback Reframe the Risk‑Reward in Its Allergy Franchise?  Yahoo Finance

Does Aquestive Therapeutics (AQST) FDA Packaging Setback Reframe the Risk‑Reward in Its Allergy Franchise? - Yahoo Finance

Click here to get full coverage on AQST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aquestive Therapeutics, Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

AQST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aquestive Therapeutics, Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit!  ACCESS Newswire

AQST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aquestive Therapeutics, Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

Click here to get full coverage on Aquestive Therapeutics (AQST) Reports Q3 Loss, Lags Revenue Estimates - Yahoo Finance

Aquestive Therapeutics (AQST) Reports Q3 Loss, Lags Revenue Estimates  Yahoo Finance

Aquestive Therapeutics (AQST) Reports Q3 Loss, Lags Revenue Estimates - Yahoo Finance

Click here to get full coverage on Aquestive Therapeutics, Inc. (NASDAQ:AQST) Released Earnings Last Week And Analysts Lifted Their Price Target To US$10.10 - Yahoo Finance

Aquestive Therapeutics, Inc. (NASDAQ:AQST) Released Earnings Last Week And Analysts Lifted Their Price Target To US$10.10  Yahoo Finance

Aquestive Therapeutics, Inc. (NASDAQ:AQST) Released Earnings Last Week And Analysts Lifted Their Price Target To US$10.10 - Yahoo Finance

Click here to get full coverage on Compared to Estimates, Aquestive Therapeutics (AQST) Q4 Earnings: A Look at Key Metrics - Yahoo Finance

Compared to Estimates, Aquestive Therapeutics (AQST) Q4 Earnings: A Look at Key Metrics  Yahoo Finance

Compared to Estimates, Aquestive Therapeutics (AQST) Q4 Earnings: A Look at Key Metrics - Yahoo Finance

Click here to get full coverage on Aquestive Therapeutics Inc (AQST) Q3 2025 Earnings Report Preview: What To Look For - Yahoo Finance

Aquestive Therapeutics Inc (AQST) Q3 2025 Earnings Report Preview: What To Look For  Yahoo Finance

Aquestive Therapeutics Inc (AQST) Q3 2025 Earnings Report Preview: What To Look For - Yahoo Finance

Click here to get full coverage on Portnoy Law Firm Announces Class Action on Behalf of Aquestive Therapeutics, Inc. Investors - GlobeNewswire

Portnoy Law Firm Announces Class Action on Behalf of Aquestive Therapeutics, Inc. Investors  GlobeNewswire

Portnoy Law Firm Announces Class Action on Behalf of Aquestive Therapeutics, Inc. Investors - GlobeNewswire

Click here to get full coverage on Aquestive Therapeutics Inc. (AQST) Stock Falls on Q4 2025 Earnings - Quiver Quantitative

Aquestive Therapeutics Inc. (AQST) Stock Falls on Q4 2025 Earnings  Quiver Quantitative

Aquestive Therapeutics Inc. (AQST) Stock Falls on Q4 2025 Earnings - Quiver Quantitative

Click here to get full coverage on Are Medical Stocks Lagging Aquestive Therapeutics (AQST) This Year? - Yahoo Finance

Are Medical Stocks Lagging Aquestive Therapeutics (AQST) This Year?  Yahoo Finance

Are Medical Stocks Lagging Aquestive Therapeutics (AQST) This Year? - Yahoo Finance

Click here to get full coverage on Here's What Key Metrics Tell Us About Aquestive Therapeutics (AQST) Q3 Earnings - Yahoo Finance

Here's What Key Metrics Tell Us About Aquestive Therapeutics (AQST) Q3 Earnings  Yahoo Finance

Here's What Key Metrics Tell Us About Aquestive Therapeutics (AQST) Q3 Earnings - Yahoo Finance

Click here to get full coverage on Aquestive Therapeutics (AQST) grants 60,000 performance stock units to officer - Stock Titan

Aquestive Therapeutics (AQST) grants 60,000 performance stock units to officer  Stock Titan

Aquestive Therapeutics (AQST) grants 60,000 performance stock units to officer - Stock Titan

Click here to get full coverage on AQST Investors Have Opportunity to Lead Aquestive Therapeutics, Inc. Securities Fraud Lawsuit - The Killeen Daily Herald

AQST Investors Have Opportunity to Lead Aquestive Therapeutics, Inc. Securities Fraud Lawsuit  The Killeen Daily Herald

AQST Investors Have Opportunity to Lead Aquestive Therapeutics, Inc. Securities Fraud Lawsuit - The Killeen Daily Herald

Click here to get full coverage on Aquestive Therapeutics (AQST) CEO awarded 293,100 performance stock units tied to share price - Stock Titan

Aquestive Therapeutics (AQST) CEO awarded 293,100 performance stock units tied to share price  Stock Titan

Aquestive Therapeutics (AQST) CEO awarded 293,100 performance stock units tied to share price - Stock Titan

Click here to get full coverage on Aquestive Therapeutics (AQST) CFO receives 82,500 performance stock units tied to share price - Stock Titan

Aquestive Therapeutics (AQST) CFO receives 82,500 performance stock units tied to share price  Stock Titan

Aquestive Therapeutics (AQST) CFO receives 82,500 performance stock units tied to share price - Stock Titan

Click here to get full coverage on Aquestive Therapeutics Stock (AQST) Opinions on FDA Deficiency Notice | AQST Stock News - Quiver Quantitative

Aquestive Therapeutics Stock (AQST) Opinions on FDA Deficiency Notice | AQST Stock News  Quiver Quantitative

Aquestive Therapeutics Stock (AQST) Opinions on FDA Deficiency Notice | AQST Stock News - Quiver Quantitative

Click here to get full coverage on AQST Investor Alert: AQUESTIVE THERAPEUTICS, INC. Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Analyst Slashed Price Target: Levi & Korsinsky - PR Newswire

AQST Investor Alert: AQUESTIVE THERAPEUTICS, INC. Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Analyst Slashed Price Target: Levi & Korsinsky  PR Newswire

AQST Investor Alert: AQUESTIVE THERAPEUTICS, INC. Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Analyst Slashed Price Target: Levi & Korsinsky - PR Newswire

Click here to get full coverage on Aquestive Therapeutics (AQST) awards 82,500 performance stock units to corporate secretary - Stock Titan

Aquestive Therapeutics (AQST) awards 82,500 performance stock units to corporate secretary  Stock Titan

Aquestive Therapeutics (AQST) awards 82,500 performance stock units to corporate secretary - Stock Titan

Click here to get full coverage on Aquestive (AQST) COO awarded 60,000 PSUs tied to 2025–2028 share performance - Stock Titan

Aquestive (AQST) COO awarded 60,000 PSUs tied to 2025–2028 share performance  Stock Titan

Aquestive (AQST) COO awarded 60,000 PSUs tied to 2025–2028 share performance - Stock Titan

Click here to get full coverage on Allergy emergency film from Aquestive edges toward FDA resubmission - Stock Titan

Allergy emergency film from Aquestive edges toward FDA resubmission  Stock Titan

Allergy emergency film from Aquestive edges toward FDA resubmission - Stock Titan

Click here to get full coverage on AQST SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Reminds Aquestive Therapeutics (AQST) Investors of Securities Class Action Deadline on May 4, 2026 - PR Newswire

AQST SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Reminds Aquestive Therapeutics (AQST) Investors of Securities Class Action Deadline on May 4, 2026  PR Newswire

AQST SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Reminds Aquestive Therapeutics (AQST) Investors of Securities Class Action Deadline on May 4, 2026 - PR Newswire

Click here to get full coverage on Aquestive Therapeutics, Inc. (NASDAQ:AQST) Shares May Have Slumped 36% But Getting In Cheap Is Still Unlikely - simplywall.st

Aquestive Therapeutics, Inc. (NASDAQ:AQST) Shares May Have Slumped 36% But Getting In Cheap Is Still Unlikely  simplywall.st

Aquestive Therapeutics, Inc. (NASDAQ:AQST) Shares May Have Slumped 36% But Getting In Cheap Is Still Unlikely - simplywall.st

Click here to get full coverage on Aquestive (AQST) CCO receives 67,500 performance stock units tied to share price - Stock Titan

Aquestive (AQST) CCO receives 67,500 performance stock units tied to share price  Stock Titan

Aquestive (AQST) CCO receives 67,500 performance stock units tied to share price - Stock Titan

Click here to get full coverage on AQST Stockholders Have Rights – If You Lost Money Investing - GlobeNewswire

AQST Stockholders Have Rights – If You Lost Money Investing  GlobeNewswire

AQST Stockholders Have Rights – If You Lost Money Investing - GlobeNewswire

Click here to get full coverage on Aquestive Therapeutics (AQST) Soars 14.8%: Is Further Upside Left in the Stock? - Yahoo Finance

Aquestive Therapeutics (AQST) Soars 14.8%: Is Further Upside Left in the Stock?  Yahoo Finance

Aquestive Therapeutics (AQST) Soars 14.8%: Is Further Upside Left in the Stock? - Yahoo Finance

Click here to get full coverage on AQST Shareholder Alert: May 4, 2026 Lead Plaintiff Deadline - GlobeNewswire

AQST Shareholder Alert: May 4, 2026 Lead Plaintiff Deadline  GlobeNewswire

AQST Shareholder Alert: May 4, 2026 Lead Plaintiff Deadline - GlobeNewswire

Click here to get full coverage on Aquestive Therapeutics: Post-CRL Risk, Timeline, And Valuation (NASDAQ:AQST) - Seeking Alpha

Aquestive Therapeutics: Post-CRL Risk, Timeline, And Valuation (NASDAQ:AQST)  Seeking Alpha

Aquestive Therapeutics: Post-CRL Risk, Timeline, And Valuation (NASDAQ:AQST) - Seeking Alpha

Click here to get full coverage on AQST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aquestive Therapeutics, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

AQST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aquestive Therapeutics, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit!  ACCESS Newswire

AQST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aquestive Therapeutics, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

Click here to get full coverage on Aquestive Therapeutics (AQST) Surges 7.9%: Is This an Indication of Further Gains? - Yahoo Finance

Aquestive Therapeutics (AQST) Surges 7.9%: Is This an Indication of Further Gains?  Yahoo Finance

Aquestive Therapeutics (AQST) Surges 7.9%: Is This an Indication of Further Gains? - Yahoo Finance

Click here to get full coverage on Aquestive Therapeutics (AQST) Form 3 shows CLO holding zero common stock - Stock Titan

Aquestive Therapeutics (AQST) Form 3 shows CLO holding zero common stock  Stock Titan

Aquestive Therapeutics (AQST) Form 3 shows CLO holding zero common stock - Stock Titan

Click here to get full coverage on AQUESTIVE THERAPEUTICS, INC. (AQST) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Aquestive Therapeutics, Inc. Investors of Upcoming Deadline - TMX Newsfile

AQUESTIVE THERAPEUTICS, INC. (AQST) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Aquestive Therapeutics, Inc. Investors of Upcoming Deadline  TMX Newsfile

AQUESTIVE THERAPEUTICS, INC. (AQST) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Aquestive Therapeutics, Inc. Investors of Upcoming Deadline - TMX Newsfile

Click here to get full coverage on AQST Investors Have Opportunity to Lead Aquestive Therapeutics, Inc. Securities Fraud Lawsuit - PR Newswire

AQST Investors Have Opportunity to Lead Aquestive Therapeutics, Inc. Securities Fraud Lawsuit  PR Newswire

AQST Investors Have Opportunity to Lead Aquestive Therapeutics, Inc. Securities Fraud Lawsuit - PR Newswire

Click here to get full coverage on $AQST stock is down 34% today. Here's what we see in our data. - Quiver Quantitative

$AQST stock is down 34% today. Here's what we see in our data.  Quiver Quantitative

$AQST stock is down 34% today. Here's what we see in our data. - Quiver Quantitative

Click here to get full coverage on AQUESTIVE THERAPEUTICS, INC. (AQST) SHAREHOLDER ALERT - GlobeNewswire

AQUESTIVE THERAPEUTICS, INC. (AQST) SHAREHOLDER ALERT  GlobeNewswire

AQUESTIVE THERAPEUTICS, INC. (AQST) SHAREHOLDER ALERT - GlobeNewswire

Click here to get full coverage on Aquestive says FDA cited issues with Anaphylm (AQST:NASDAQ) - Seeking Alpha

Aquestive says FDA cited issues with Anaphylm (AQST:NASDAQ)  Seeking Alpha

Aquestive says FDA cited issues with Anaphylm (AQST:NASDAQ) - Seeking Alpha

Click here to get full coverage on AQST SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds - GlobeNewswire

AQST SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds  GlobeNewswire

AQST SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds - GlobeNewswire

Click here to get full coverage on AQST Stock Plunges On An FDA Setback For Its Allergy Drug – Here’s What Has Changed - Stocktwits

AQST Stock Plunges On An FDA Setback For Its Allergy Drug – Here’s What Has Changed  Stocktwits

AQST Stock Plunges On An FDA Setback For Its Allergy Drug – Here’s What Has Changed - Stocktwits

Click here to get full coverage on Allergy rescue film setback: FDA flags Anaphylm packaging, eyed for Q3 2026 - Stock Titan

Allergy rescue film setback: FDA flags Anaphylm packaging, eyed for Q3 2026  Stock Titan

Allergy rescue film setback: FDA flags Anaphylm packaging, eyed for Q3 2026 - Stock Titan

Click here to get full coverage on Aquestive to detail Q4 2025 results March 4, investor call March 5 - Stock Titan

Aquestive to detail Q4 2025 results March 4, investor call March 5  Stock Titan

Aquestive to detail Q4 2025 results March 4, investor call March 5 - Stock Titan

Click here to get full coverage on Aquestive picks Day Pitney partner for legal post, keeps Lori Braender - Stock Titan

Aquestive picks Day Pitney partner for legal post, keeps Lori Braender  Stock Titan

Aquestive picks Day Pitney partner for legal post, keeps Lori Braender - Stock Titan

Click here to get full coverage on Dissolving allergy film for severe reactions faces fresh FDA concerns - Stock Titan

Dissolving allergy film for severe reactions faces fresh FDA concerns  Stock Titan

Dissolving allergy film for severe reactions faces fresh FDA concerns - Stock Titan

Click here to get full coverage on Aquestive Therapeutics (NASDAQ:AQST) shareholders are still up 524% over 3 years despite pulling back 6.6% in the past week - simplywall.st

Aquestive Therapeutics (NASDAQ:AQST) shareholders are still up 524% over 3 years despite pulling back 6.6% in the past week  simplywall.st

Aquestive Therapeutics (NASDAQ:AQST) shareholders are still up 524% over 3 years despite pulling back 6.6% in the past week - simplywall.st

Click here to get full coverage on Press releases provided by CNW - Techaeris

Press releases provided by CNW  Techaeris

Press releases provided by CNW - Techaeris

Click here to get full coverage on AQST UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Aquestive Therapeutics (AQST) Investors of Securities Class Action Deadline on May 4, 2026 - PR Newswire

AQST UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Aquestive Therapeutics (AQST) Investors of Securities Class Action Deadline on May 4, 2026  PR Newswire

AQST UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Aquestive Therapeutics (AQST) Investors of Securities Class Action Deadline on May 4, 2026 - PR Newswire

Click here to get full coverage on Assessing Aquestive Therapeutics (AQST) Valuation After The FDA Complete Response Letter For Anaphylm - simplywall.st

Assessing Aquestive Therapeutics (AQST) Valuation After The FDA Complete Response Letter For Anaphylm  simplywall.st

AQST

Price Chart

Key Statistics

Technicals

About AQST

Latest News

AQST Investor Alert: AQUESTIVE THERAPEUTICS, INC. - GlobeNewswire

Aquestive Therapeutics (AQST) Awaits Anaphylm NDA Approval in Q3 - Yahoo Finance

AQST Investors Have Opportunity to Lead Aquestive Therapeutics, Inc. Securities Fraud Lawsuit - Morningstar

Advanced Charts

Top Gainers

Top Losers